CN107868758A - 蛋白酶缺陷丝状真菌细胞及其使用方法 - Google Patents

蛋白酶缺陷丝状真菌细胞及其使用方法 Download PDF

Info

Publication number
CN107868758A
CN107868758A CN201710503139.1A CN201710503139A CN107868758A CN 107868758 A CN107868758 A CN 107868758A CN 201710503139 A CN201710503139 A CN 201710503139A CN 107868758 A CN107868758 A CN 107868758A
Authority
CN
China
Prior art keywords
protease
seq
cell
polypeptide
trichoderma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710503139.1A
Other languages
English (en)
Chinese (zh)
Inventor
C·兰道斯基
A·雨斯科南
J·萨里南
A·韦斯特霍尔姆-帕维南
A·卡内尔瓦
J·纳蒂南
A-L·阿尼南
N·萨洛维奥里
M·彭蒂拉
M·萨洛埃莫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glykos Finland Ltd
Original Assignee
Novartis AG
Glykos Finland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47520118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN107868758(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG, Glykos Finland Ltd filed Critical Novartis AG
Publication of CN107868758A publication Critical patent/CN107868758A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN201710503139.1A 2012-01-05 2013-01-04 蛋白酶缺陷丝状真菌细胞及其使用方法 Pending CN107868758A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261583559P 2012-01-05 2012-01-05
US61/583,559 2012-01-05
CN201380012940.6A CN104245919B (zh) 2012-01-05 2013-01-04 蛋白酶缺陷丝状真菌细胞及其使用方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201380012940.6A Division CN104245919B (zh) 2012-01-05 2013-01-04 蛋白酶缺陷丝状真菌细胞及其使用方法

Publications (1)

Publication Number Publication Date
CN107868758A true CN107868758A (zh) 2018-04-03

Family

ID=47520118

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710503139.1A Pending CN107868758A (zh) 2012-01-05 2013-01-04 蛋白酶缺陷丝状真菌细胞及其使用方法
CN201380012940.6A Expired - Fee Related CN104245919B (zh) 2012-01-05 2013-01-04 蛋白酶缺陷丝状真菌细胞及其使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201380012940.6A Expired - Fee Related CN104245919B (zh) 2012-01-05 2013-01-04 蛋白酶缺陷丝状真菌细胞及其使用方法

Country Status (14)

Country Link
US (5) US9567596B2 (enExample)
EP (2) EP3358000A3 (enExample)
JP (2) JP6245528B2 (enExample)
KR (1) KR20140114860A (enExample)
CN (2) CN107868758A (enExample)
AU (1) AU2013207165B2 (enExample)
BR (1) BR112014016587A2 (enExample)
CA (1) CA2861697C (enExample)
DK (1) DK2800809T3 (enExample)
IL (1) IL233052A0 (enExample)
MX (1) MX355226B (enExample)
RU (1) RU2645252C2 (enExample)
SG (1) SG11201403818XA (enExample)
WO (1) WO2013102674A2 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013207165B2 (en) * 2012-01-05 2018-10-04 Glykos Finland Oy Protease deficient filamentous fungal cells and methods of use thereof
EP2971030B8 (en) * 2013-03-14 2018-12-05 Glycobia, Inc Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes
CA2916905A1 (en) 2013-07-10 2015-01-15 Novartis Ag Multiple proteases deficient filamentous fungal cells and methods of use thereof
CN108064266A (zh) * 2014-07-21 2018-05-22 格利科斯芬兰公司 在丝状真菌中具有哺乳动物样n-聚糖的糖蛋白的制备
JP6878275B2 (ja) * 2014-10-24 2021-05-26 デュポン ニュートリション バイオサイエンシス エーピーエス プロリン耐性トリペプチジルペプチダーゼおよびその使用
CN107075534A (zh) * 2014-10-24 2017-08-18 丹尼斯科美国公司 使用三肽基肽酶制备醇的方法
US10883131B2 (en) 2015-02-20 2021-01-05 Roal Oy Methods for controlling protease production
CN106190874B (zh) * 2015-05-06 2020-06-26 中国科学院天津工业生物技术研究所 一种强化丝状真菌蛋白质生产的方法
CN104990881A (zh) * 2015-07-09 2015-10-21 辽宁省农业科学院蔬菜研究所 一种快速检测羊肚菌菌丝活力的方法
EP3380609B1 (en) * 2015-11-24 2020-11-11 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
SG11201804966VA (en) * 2015-12-17 2018-07-30 Evonik Degussa China Co Ltd Gene cassette for homologous recombination knock-out in yeast cells
WO2017115005A1 (en) 2015-12-29 2017-07-06 Teknologian Tutkimuskeskus Vtt Oy Production of fusion proteins in trichoderma
US10876103B2 (en) 2016-10-04 2020-12-29 Danisco Us Inc Protein production in filamentous fungal cells in the absence of inducing substrates
CN108588060B (zh) 2017-03-07 2020-12-01 武汉康复得生物科技股份有限公司 一种用丝状真菌宿主细胞表达的重组草酸脱羧酶
US11385238B2 (en) * 2017-06-30 2022-07-12 Amgen Inc. Methods of protein clips recovery
EP3662068B1 (en) * 2017-07-31 2023-10-18 Melt&Marble AB Fungal cell with improved protein production capacity
WO2019046232A1 (en) 2017-08-30 2019-03-07 Novozymes A/S Combined use of an endo-protease of the m35 family and an exo-protease of the s53 family in the fermentation of starch
JP7234932B2 (ja) * 2017-10-10 2023-03-08 味の素株式会社 タンパク質の製造法
WO2019175477A1 (en) 2018-03-12 2019-09-19 Teknologian Tutkimuskeskus Vtt Oy A subunit vaccine against porcine post-weaning diarrhoea
US10787656B2 (en) * 2018-05-04 2020-09-29 Fomia BioSolutions, Inc. Variant alkaline protease enzyme compositions and methods
JP7388194B2 (ja) * 2018-08-29 2023-11-29 東レ株式会社 トリコデルマ・リーセイの変異株およびそれを用いたタンパク質の製造方法
CN111088244B (zh) * 2018-10-23 2023-03-21 中国科学院天津工业生物技术研究所 蛋白酶基因在促进纤维素酶生产和复杂氮源利用中的应用
WO2021007630A1 (pt) * 2019-07-16 2021-01-21 Centro Nacional De Pesquisa Em Energia E Materiais Linhagem de fungo trichoderma modificada para a produção de coquetel enzimático
CN110724644A (zh) * 2019-12-05 2020-01-24 西北农林科技大学 一种产重组人胰岛素原的里氏木霉工程菌及其应用
CN115836127A (zh) 2020-06-11 2023-03-21 味之素株式会社 蛋白的制造方法
EP4189061A1 (en) 2020-07-31 2023-06-07 Biotalys NV Methods of increasing recombinant protein yields
CN113388532B (zh) * 2021-06-16 2023-04-07 华东理工大学 一种用于生产天冬酰胺酶的重组里氏木霉及其构建方法和应用
US20240376511A1 (en) 2021-07-19 2024-11-14 Danisco Us Inc. Compositions and methods for enhanced protein production in fungal cells
CA3234874A1 (en) 2021-10-15 2023-04-20 Martijn Scheffers Glucoamylase variants and methods for use thereof
US20250320512A1 (en) 2021-12-01 2025-10-16 Danisco Us Inc. Compositions and methods for enhanced protein production in fungal cells
WO2023148301A1 (en) 2022-02-02 2023-08-10 Biotalys NV Modified microbial cells and uses thereof
CN114907992B (zh) * 2022-05-18 2023-06-16 塔里木大学 拮抗植物病原菌的菌株c11及其应用
CN115820692B (zh) * 2022-08-17 2024-05-10 大连理工大学 一种能同时达到去除羊毛虱卵壳与防毡缩的蛋白酶与应用
AU2024271436A1 (en) * 2023-05-15 2025-11-13 Sangamo Therapeutics, Inc. Engineered blood brain barrier penetrant aav capsids
KR20250004526A (ko) * 2023-06-29 2025-01-08 씨제이제일제당 (주) 아스파르트산 프로테아제 변이체
WO2025230415A1 (en) 2024-04-30 2025-11-06 Ginkgo Bioworks Netherlands B.V. Host cells expressing optb protein variants and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1341149A (zh) * 1999-02-22 2002-03-20 诺维信公司 草酰乙酸水解酶缺陷型真菌宿主细胞
CN1342204A (zh) * 1999-02-02 2002-03-27 诺沃奇梅兹生物技术有限公司 用于在真菌细胞中生产多肽的方法
WO2008073914A2 (en) * 2006-12-10 2008-06-19 Dyadic International Inc. Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi
CN101292024A (zh) * 2005-10-17 2008-10-22 诺维信公司 用于表达抗体的真菌突变体的用途
WO2011075677A2 (en) * 2009-12-18 2011-06-23 Novozymes, Inc. Methods for producing polypeptides in protease-deficient mutants of trichoderma
CN102216466A (zh) * 2008-11-18 2011-10-12 丹尼斯科美国公司 用于改变蛋白质产量的具有受损的ptrB活性的丝状真菌

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4758512A (en) 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
CA1333777C (en) 1988-07-01 1995-01-03 Randy M. Berka Aspartic proteinase deficient filamentous fungi
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
GB2276169A (en) 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
US5846802A (en) 1992-04-15 1998-12-08 Buxton; Frank Fungal Protease
AU680816B2 (en) 1992-05-15 1997-08-14 Quest International B.V. Cloning and expression of DNA encoding a ripening form of a polypeptide having phamnogalacturonase activity
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
DK52393D0 (enExample) 1993-05-05 1993-05-05 Novo Nordisk As
US5674728A (en) 1993-11-03 1997-10-07 Novartis Corporation Aspergillus niger vacuolar aspartyl protease
FI965031A0 (fi) 1994-06-17 1996-12-16 Novo Nordisk As Sieni, jossa AreA-geeni on muunnettu, ja Aspergillus oryzaesta peräisin oleva areA-geeni
US6060305A (en) 1994-06-30 2000-05-09 Novo Nordisk Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system
KR970707277A (ko) 1994-11-08 1997-12-01 리제 아빌드카르트 리베르크 트리펩티딜 아미노펩티다제(tripeptidyl aminopeptidase)
DE69636899T2 (de) 1995-03-20 2007-10-31 Novozymes A/S Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
AU7112796A (en) * 1995-09-27 1997-04-17 Chiron Corporation Method of making a protease deficient host
CN1160465C (zh) 1995-12-15 2004-08-04 诺沃奇梅兹有限公司 其中areA、pepC和/或pepE基因已被灭活的真菌
US5776730A (en) 1995-12-15 1998-07-07 University Of Hawaii Neurospora hosts for the production of recombinant proteins, and methods for producing same
AU1750697A (en) 1996-01-19 1997-08-11 Novo Nordisk Biotech, Inc. Morphological mutants of filamentous fungi
DE69735199T2 (de) 1996-03-27 2006-09-21 Novozymes A/S Alkaline-phosphatase-defiziente, filamentöse pilze
JP2000511429A (ja) 1996-06-05 2000-09-05 ギスト ブロカデス ベスローテン フェンノートシャップ 真菌メタロプロテアーゼ遺伝子
DE69734936T2 (de) 1996-09-19 2006-08-24 Novozymes A/S Wirtszellen und methoden für die produktion von proteinen
US7883872B2 (en) 1996-10-10 2011-02-08 Dyadic International (Usa), Inc. Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
US6806062B1 (en) 1998-10-05 2004-10-19 Novozymes A/S Fungal transcriptional activator useful in methods for producing polypeptides
CN1425068B (zh) 2000-03-14 2011-05-18 诺维信公司 在制备多肽的方法中有效的真菌转录激活因子
CN1380905A (zh) * 2000-04-13 2002-11-20 马克·阿龙·埃马尔法尔布 丝状真菌中dna表达文库的高通量筛选
KR20020026456A (ko) 2000-04-13 2002-04-10 에말파브 마크 아론 사상균에서 발현된 ｄｎａ 라이브러리의 고산출량 스크리닝
PT1326957E (pt) 2000-12-07 2004-09-30 Dsm Ip Assets Bv Metodo para a prevencao ou reducao de turvacao em bebidas
NZ527422A (en) 2001-02-23 2005-02-25 Dsm Ip Assets B Tripeptidyl aminopeptidases from Aspergillus niger
US7404977B2 (en) 2001-12-21 2008-07-29 Dsm Ip Assets B.V. Rennets
US20040018573A1 (en) 2002-04-18 2004-01-29 Power Scott D Production of functional antibodies in filamentous fungi
WO2004067709A2 (en) 2003-01-17 2004-08-12 Elitra Pharmaceuticals, Inc. Identification of essential genes of aspergillus fumigatus and methods of use
US7303877B2 (en) 2003-03-31 2007-12-04 Novozymes, Inc. Methods for producing biological substances in enzyme-deficient mutants of Aspergillus
WO2005056772A1 (en) 2003-12-09 2005-06-23 Novozymes Inc. Methods for eliminating or reducing the expression of genes in filamentous fungal strains
GB0405659D0 (en) 2004-03-12 2004-04-21 Horticulture Res Internat Altered expression in filamentous fungi
DK1756145T3 (da) 2004-06-16 2014-09-29 Dsm Ip Assets Bv Produktion af polypeptider ved hjælp af forbedret sekretion
US7794974B2 (en) 2004-10-12 2010-09-14 Dsm Ip Assets B.V. Fungal transcriptional activators useful in methods for producing a polypeptide
GB0424940D0 (en) 2004-11-11 2004-12-15 Danisco Transcription factors
BRPI0519766A2 (pt) 2004-12-30 2009-03-10 Genencor Int proteases Ácidas féngicas
EP2123746B1 (en) 2005-04-12 2016-11-16 Danisco US Inc. Gene inactivated mutants with altered protein production
EP1930428B1 (en) 2005-08-03 2010-12-01 Asahi Glass Company, Limited transformed yeast host cells AND METHOD OF PRODUCING FOREIGN PROTEIN
CN101454455A (zh) 2005-11-29 2009-06-10 帝斯曼知识产权资产管理有限公司 在基因表达中有用的转录激活因子的dna结合位点
BRPI0713795B1 (pt) 2006-06-29 2018-03-20 Dsm Ip Assets B.V. Método de otimização de uma sequência de nucleotídeos codificadora que codifica uma sequência de aminoácidos predeterminada
US8216844B2 (en) 2006-08-29 2012-07-10 Danisco Us Inc. Compositions and methods for improved protein production
WO2008053018A2 (en) 2006-11-02 2008-05-08 Dsm Ip Assets B.V. Improved production of secreted proteins by filamentous fungi
US9862956B2 (en) * 2006-12-10 2018-01-09 Danisco Us Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
CN105420268A (zh) 2006-12-21 2016-03-23 诺维信股份有限公司 通过移行rna干扰来降低或消除丝状真菌菌株中的基因表达的方法
EP2134853B1 (en) * 2007-04-03 2018-07-18 Oxyrane UK Limited Glycosylation of molecules
EP2152892B1 (en) 2007-05-21 2013-05-01 Danisco US, Inc., Genencor Division Method for introducing nucleic acids into fungal cells
WO2009058956A1 (en) * 2007-11-01 2009-05-07 Danisco Us, Inc. Signal sequences and co-expressed chaperones for improving protein production in a host cell
EP2220110A1 (en) 2007-12-06 2010-08-25 Novozymes A/S Fungal pepc inhibitor
US20090253173A1 (en) 2008-04-08 2009-10-08 Danisco Us Inc., Genencor Division Filamentous fungi with inactivated protease genes for altered protein production
AU2009266989B2 (en) 2008-07-03 2013-05-02 Pfenex, Inc. High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein
CN102099466A (zh) 2008-07-29 2011-06-15 丹尼斯科美国公司 在丝状真菌细胞中增加天冬氨酸蛋白酶的产生
CN102227502B (zh) 2008-09-30 2016-01-13 诺维信股份有限公司 在镶片镰孢的酶缺陷突变体中产生多肽的方法
US9493759B2 (en) 2008-12-12 2016-11-15 Novozymes, Inc. Polypeptides having aspartic endopeptidase activity and polynucleotides encoding same
MX2011009636A (es) 2009-03-16 2011-11-29 Dyadic Nederland B V Sistema de producciónj de proteína de chrysosporium lucknowense.
MX2012004381A (es) 2009-10-16 2012-06-01 Merck Sharp & Dohme Metodo para producir proteinas en pichia pastoris que carecen de actividad de entrelazamiento detectable con anticuerpos contra antigenos de la celula hospedera.
US20120213728A1 (en) 2009-10-30 2012-08-23 Merck Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris
CN102725396A (zh) 2009-10-30 2012-10-10 默沙东公司 在缺乏二肽基氨肽酶活性的巴斯德毕赤酵母中生产治疗性蛋白的方法
IN2012DN03823A (enExample) 2009-10-30 2015-08-28 Merck Sharp & Dohme
CN102834509A (zh) * 2009-11-19 2012-12-19 奥克西雷恩英国有限公司 生成哺乳动物样复合n-聚糖的酵母菌株
EP2515932A2 (en) 2009-12-21 2012-10-31 Centre Hospitalier Universitaire Vaudois (CHUV) Synergic action of a prolyl protease and tripeptidyl proteases
AU2011220878A1 (en) 2010-02-24 2012-08-23 Merck Sharp & Dohme Corp. Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris
WO2012021883A2 (en) 2010-08-13 2012-02-16 Dyadic International, Inc. Novel fungal enzymes
US9322027B2 (en) 2010-08-20 2016-04-26 Shell Oil Company Expression constructs comprising fungal promoters
WO2012048334A2 (en) 2010-10-08 2012-04-12 Dyadic International (Usa) Inc. Novel fungal proteases
ES2604114T3 (es) 2010-11-02 2017-03-03 Codexis, Inc. Cepas de hongos mejoradas
IN2014CN02136A (enExample) * 2011-08-24 2015-05-29 Novozymes Inc
EP2760997A4 (en) 2011-09-30 2015-02-11 Codexis Inc MUSHROOM PROTEASE
AU2013207165B2 (en) 2012-01-05 2018-10-04 Glykos Finland Oy Protease deficient filamentous fungal cells and methods of use thereof
CA2891417A1 (en) 2012-11-20 2014-05-30 Codexis, Inc. Recombinant fungal polypeptides

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1342204A (zh) * 1999-02-02 2002-03-27 诺沃奇梅兹生物技术有限公司 用于在真菌细胞中生产多肽的方法
CN1341149A (zh) * 1999-02-22 2002-03-20 诺维信公司 草酰乙酸水解酶缺陷型真菌宿主细胞
CN101292024A (zh) * 2005-10-17 2008-10-22 诺维信公司 用于表达抗体的真菌突变体的用途
WO2008073914A2 (en) * 2006-12-10 2008-06-19 Dyadic International Inc. Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi
CN102216466A (zh) * 2008-11-18 2011-10-12 丹尼斯科美国公司 用于改变蛋白质产量的具有受损的ptrB活性的丝状真菌
WO2011075677A2 (en) * 2009-12-18 2011-06-23 Novozymes, Inc. Methods for producing polypeptides in protease-deficient mutants of trichoderma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DIEGO MARTINEZ ET AL.: "Genome sequencing and analysis of the", 《NATURE BIOTECHNOLOGY》 *

Also Published As

Publication number Publication date
CN104245919B (zh) 2017-07-14
WO2013102674A2 (en) 2013-07-11
MX2014008272A (es) 2015-02-24
CA2861697A1 (en) 2013-07-11
DK2800809T3 (en) 2018-05-22
BR112014016587A2 (pt) 2020-10-27
US20210139922A1 (en) 2021-05-13
RU2014132178A (ru) 2016-02-20
JP6245528B2 (ja) 2017-12-13
IL233052A0 (en) 2014-07-31
KR20140114860A (ko) 2014-09-29
CA2861697C (en) 2022-03-15
CN104245919A (zh) 2014-12-24
EP3358000A2 (en) 2018-08-08
AU2013207165B2 (en) 2018-10-04
US10731168B2 (en) 2020-08-04
EP2800809A2 (en) 2014-11-12
US11827891B2 (en) 2023-11-28
AU2013207165A1 (en) 2014-07-03
EP3358000A3 (en) 2018-12-19
US20190233831A1 (en) 2019-08-01
SG11201403818XA (en) 2014-08-28
JP2015512611A (ja) 2015-04-30
JP2018038419A (ja) 2018-03-15
US20220290165A1 (en) 2022-09-15
MX355226B (es) 2018-03-23
RU2645252C2 (ru) 2018-02-19
WO2013102674A3 (en) 2013-11-14
US9567596B2 (en) 2017-02-14
US20170275634A1 (en) 2017-09-28
US20140370546A1 (en) 2014-12-18
US11180767B2 (en) 2021-11-23
EP2800809B1 (en) 2018-03-07
US10240159B2 (en) 2019-03-26

Similar Documents

Publication Publication Date Title
CN107868758A (zh) 蛋白酶缺陷丝状真菌细胞及其使用方法
US10988791B2 (en) Multiple proteases deficient filamentous fungal cells and methods of use thereof
AU2015293949B2 (en) Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
CN105492457A (zh) O-甘露糖基转移酶缺陷的丝状真菌细胞及其使用方法
KR20080098298A (ko) 야로위아 리폴리티카 유래의 신규 ＹｌＭＰＯ１ 유전자 및이의 파쇄 균주를 이용한 만노스 인산이 제거된 당단백질생산 방법

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20180906

Address after: Helsinki

Applicant after: Glykos Finland O. Y.

Address before: Basel

Applicant before: Novartis Ag

Applicant before: Glykos Finland O. Y.

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180403